CXCL12 and neoplasm: To provide more evidence that IL-2 augments the TDLN B cell killer/effector function via the CXCR4/CXCL12 axis, we performed experiments to compare the CXCL12 production by 4T1 tumor cells in the presence or absence of IL-2.